tiprankstipranks
GH Research Faces Growing Losses in Q3 2024
Company Announcements

GH Research Faces Growing Losses in Q3 2024

GH Research (GHRS) has released an update.

Pick the best stocks and maximize your portfolio:

GH Research reports a significant increase in losses for the third quarter of 2024, with a total operating loss of $12.1 million, compared to $5.6 million in the same period last year. The growing expenses in research and development and general administration are key contributors to the widening deficit. Investors might find these figures concerning as the company navigates its financial challenges.

For further insights into GHRS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskGH Research PLC Attends Key Neuropsychopharmacology Conference
TipRanks Auto-Generated NewsdeskGH Research Q3 2024 Results and Clinical Updates
TheFlyGH Research price target lowered to $28 from $31 at Canaccord
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App